Collegium Pharmaceutical (COLL) Gross Profit Growth (1y) (2017 - 2026)
Collegium Pharmaceutical (COLL) Gross Profit Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 90.13 Bn | 88.27 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 5.06% |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | 2.59% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -18.38% |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn | -7.66% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | -0.34% |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn | 42.12% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 14.77% |
| 10 | Collegium Pharmaceutical | 1.15 Bn | 857.99 Mn | 117.25 Mn | 20.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.47% |
| Dec 31, 2025 | 30.61% |
| Sep 30, 2025 | 33.45% |
| Jun 30, 2025 | 19.36% |
| Mar 31, 2025 | 6.42% |
| Dec 31, 2024 | 3.87% |
| Sep 30, 2024 | 20.52% |
| Jun 30, 2024 | 23.00% |
| Mar 31, 2024 | 18.16% |
| Dec 31, 2023 | 90.06% |
| Sep 30, 2023 | 36.49% |
| Jun 30, 2023 | 40.99% |
| Mar 31, 2023 | 59.60% |
| Dec 31, 2022 | 3,835.11% |
| Sep 30, 2022 | 27.60% |
| Jun 30, 2022 | 4.23% |
| Mar 31, 2022 | -12.77% |
| Dec 31, 2021 | -103.01% |
| Sep 30, 2021 | -4.32% |
| Jun 30, 2021 | 3.88% |